179 related articles for article (PubMed ID: 1284005)
1. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease].
Dobrotvorskaia TE; Rybakova MK; Suprun EK; Arifullin ShS
Ter Arkh; 1992; 64(12):30-2. PubMed ID: 1284005
[No Abstract] [Full Text] [Related]
2. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
Ol'binskaia LI; Rybakov MA; Sizova ZhM
Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
[TBL] [Abstract][Full Text] [Related]
3. [Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
Dobrotvorskaia TE; Koroleva ON; Gordina OV; Marakanova AV
Klin Med (Mosk); 1996; 74(3):51-3. PubMed ID: 8926706
[No Abstract] [Full Text] [Related]
4. [Cordanum in the treatment of ischemic heart disease with stable extrasystole in the middle-aged and elderly].
Korkushko OV; Butenko AG; Shatilo VB
Sov Med; 1986; (8):3-8. PubMed ID: 2430340
[No Abstract] [Full Text] [Related]
5. [Anti-arrhythmic effect of cordaron in patients with unstable stenocardia and myocardial infarction].
Dobrotvorskaia TE; Mustafaev FM; Abdullaeva TI; Matsueva NL
Klin Med (Mosk); 1989 Nov; 67(11):40-3. PubMed ID: 2483189
[TBL] [Abstract][Full Text] [Related]
6. [The effects of propafenone in the treatment of ventricular arrhythmias with a malignant potential for resistance to conventional anti-arrhythmia medication].
Câmpeanu A; Rădoi M; Serban-Pârâu G; Pleşca O; Nuţă M; Teodorescu V; Titirigă M
Med Interna; 1993; 45(1-2):35-41. PubMed ID: 8081689
[No Abstract] [Full Text] [Related]
7. [The potentials of combined anti-arrhythmia therapy with the use of neuroactive amino acids in patients with ischemic heart disease].
Skibitskiĭ VV
Ter Arkh; 1992; 64(8):25-9. PubMed ID: 1279829
[No Abstract] [Full Text] [Related]
8. [The cardiotoxic properties of kordaron in acute myocardial ischemia and infarct].
Spasov AA; Gurova NA; Panchenko TI
Eksp Klin Farmakol; 1998; 61(6):25-30. PubMed ID: 9929812
[TBL] [Abstract][Full Text] [Related]
9. [The anti-arrhythmia action of tiracizine in patients with ischemic heart disease and decreased myocardial contractile function].
Mishin IuI; Kliachkina IL; Ivashkin VT; Min'kova TI; Bannikova SD
Voen Med Zh; 1997 Jun; 318(6):44-7. PubMed ID: 9412062
[No Abstract] [Full Text] [Related]
10. [The characteristics of the autonomic regulation of the heart rate in patients with IHD and ventricular arrhythmias under obzidan therapy].
Belogubets VI; Polevaia TIu; Afonskaia NI; Smetnev AS
Ter Arkh; 1994; 66(8):32-4. PubMed ID: 7527162
[TBL] [Abstract][Full Text] [Related]
11. [Arrest of the painful syndrome by moradol and nubain in patients with ischemic heart disease].
Litovchenko VS; Blinov AV
Anesteziol Reanimatol; 1996; (4):30-1. PubMed ID: 8975566
[TBL] [Abstract][Full Text] [Related]
12. [The circadian rhythms of myocardial ischemia and ectopic activity in patients with unstable stenocardia].
Malinovskaia IE; Tashchuk VK
Vrach Delo; 1991 Oct; (10):37-9. PubMed ID: 1725074
[TBL] [Abstract][Full Text] [Related]
13. [The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy].
Palazzuoli V; Mondillo S; Faglia S; D'Aprile N; Camporeale A; Gennari C
Clin Ter; 1993 Feb; 142(2):155-9. PubMed ID: 7682488
[TBL] [Abstract][Full Text] [Related]
14. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
Dunaev VV; Kraĭdashenko OV; Berezin AE
Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of the effectiveness of mexitil in the treatment of patients with extrasystole in old and advanced age].
Korkuschko OW; Butenko AG; Schatilo WB
Z Gerontol; 1987; 20(3):149-53. PubMed ID: 2442897
[TBL] [Abstract][Full Text] [Related]
16. [Spontaneous variability of ventricular arrhythmias and evaluation of antiarrhythmic drug efficacy--studies evaluating the correlation between ventricular ectopic beat frequency and heart rate].
Ito M; Tsumabuki S; Maeda Y; Arita M
Rinsho Byori; 1986 Aug; 34(8):939-48. PubMed ID: 2431174
[No Abstract] [Full Text] [Related]
17. [Characteristics of the ritmilen treatment of stable extrasystole in middle-aged and elderly ischemic heart disease patients].
Korkushko OV; Butenko AG; Ignatova AN
Klin Med (Mosk); 1985 Apr; 63(4):30-6. PubMed ID: 2411997
[No Abstract] [Full Text] [Related]
18. [Postinfarct ventricular extrasystole and the use of anti-arrhythmic drugs: a danger anticipated by electrophysiologists].
Farré J; Brugada P
Rev Esp Cardiol; 1989 Oct; 42(8):498-500. PubMed ID: 2481326
[No Abstract] [Full Text] [Related]
19. [The pharmacodynamics of anti-arrhythmia preparations and their different combinations when administered intravenously].
Abdalla A; Mazur NA; Iavorskaia NV; Kheĭmets GI; Chikovani SI; Potekhin EG
Ter Arkh; 1992; 64(8):20-5. PubMed ID: 1279828
[No Abstract] [Full Text] [Related]
20. [Treatment of ventricular extrasystole with mexiletine and Neo-gilurytmal in myocardial infarct patients].
Loskot F; Bauer U
Adv Clin Pharmacol; 1978; 16():75-80. PubMed ID: 80103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
